Infinity Pharmaceuticals Inc (NASDAQ:INFI)

2.05
Delayed Data
As of Jun 22
 +0.33 / +19.19%
Today’s Change
0.93
Today|||52-Week Range
3.75
+0.99%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues165.0M109.1M18.7M6.0M
 
 
 
 
 
Depreciation And Amortization1.8M2.3M3.4M1.7M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses171.1M233.9M139.9M40.7M
 
 
 
 
 
Research And Development143.6M199.1M106.9M20.8M
 
 
 
 
 
Total Operating Expenses172.9M236.2M143.3M42.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.9M-127.1M-124.6M-36.4M
 
 
 
 
 
Extraordinary Credit0.000.00114.9M0.00
 
 
Extraordinary Charge0.000.00-21.2M-6.9M
 
 
 
Interest Expense On Debt9.6M1.4M1.2M1.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-17.2M-128.0M-30.1M-42.6M
 
 
 
 
 
Income Taxes-183.0K-335.0K0.00-720.0K
 
 
 
 
Net Income-17.4M-128.4M-30.1M-41.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS48.6M49.1M49.6M50.6M
 
 
 
 
 
Shares To Calculate EPS Diluted48.6M49.1M49.6M50.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.36-$2.62-$0.61-$0.83
 
 
 
 
 
EPS Diluted-$0.36-$2.62-$0.61-$0.83